Table 2.
Variables | Progression (n) |
Crude HR (95% CI) |
P-value* | Adjusted HR (95% CI)a | P-value* |
---|---|---|---|---|---|
Gender | |||||
Male | 103 | 1.06 (0.79–1.41) | 0.689 | - | - |
Female | 85 | 1 | - | ||
Age group (years) | |||||
6–15 | 9 | 1 | - | - | |
16–29 | 27 | 0.78 (0.36–1.66) | 0.525 | - | |
30–59 | 123 | 1.53 (0.78–3.02) | 0.213 | - | |
60 or older | 29 | 1.23 (0.58–2.61) | 0.579 | - | |
Operational classification- | |||||
Paucibacillary | 123 | 1 | - | - | |
Multibacillary | 65 | 0.82 (0.60–1.11) | 0.198 | - | |
Leprosy reaction during treatment | |||||
Yes | 71 | 2.09 (1.55–2.82) | 0.001 | 1.65 (1.13–2.40) | 0.008 |
No | 116 | 1 | 1 | ||
Complaints during treatment | |||||
Yes | 82 | 2.01 (1.49–2.70) | 0.001 | 1.76 (1.29–2.40) | 0.001 |
No | 102 | 1 | 1 |
a Variables adjusted by leprosy reaction during treatment, complaints during treatment
*P-value according to Wald test
-: Not applicable; HR - Hazard ratio; CI - Confidence interval.